These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1045 related articles for article (PubMed ID: 7588257)
21. PYY and GLP-1 contribute to feedback inhibition from the canine ileum and colon. Wen J; Phillips SF; Sarr MG; Kost LJ; Holst JJ Am J Physiol; 1995 Dec; 269(6 Pt 1):G945-52. PubMed ID: 8572226 [TBL] [Abstract][Full Text] [Related]
22. Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections. Nauck MA; Siemsglüss J; Orskov C; Holst JJ Z Gastroenterol; 1996 Mar; 34(3):159-66. PubMed ID: 8650968 [TBL] [Abstract][Full Text] [Related]
23. Cooperative effects of bombesin, substance P and methacholine on the release of intestinal neurotensin in rats. Herrmann C; Cuber JC; Bernard C; Chayvialle JA Regul Pept; 1992 Jan; 37(2):123-34. PubMed ID: 1371613 [TBL] [Abstract][Full Text] [Related]
24. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas. Fehmann HC; Göke R; Göke B; Bächle R; Wagner B; Arnold R Biochim Biophys Acta; 1991 Feb; 1091(3):356-63. PubMed ID: 1705823 [TBL] [Abstract][Full Text] [Related]
25. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Herrmann C; Göke R; Richter G; Fehmann HC; Arnold R; Göke B Digestion; 1995; 56(2):117-26. PubMed ID: 7750665 [TBL] [Abstract][Full Text] [Related]
26. Neuromedin-N is not released with neurotensin from rat ileum. Cuber JC; Herrmann C; Kitabgi P; Bosshard A; Bernard C; De Nadai F; Chayvialle JA Endocrinology; 1990 Mar; 126(3):1584-92. PubMed ID: 2307120 [TBL] [Abstract][Full Text] [Related]
27. Glucagon-like peptide-1 7-36 amide and peptide YY have additive inhibitory effect on gastric acid secretion in man. Wettergren A; Maina P; Boesby S; Holst JJ Scand J Gastroenterol; 1997 Jun; 32(6):552-5. PubMed ID: 9200286 [TBL] [Abstract][Full Text] [Related]
29. On the relationship between glucose absorption and glucose-stimulated secretion of GLP-1, neurotensin, and PYY from different intestinal segments in the rat. Kuhre RE; Christiansen CB; Saltiel MY; Wewer Albrechtsen NJ; Holst JJ Physiol Rep; 2017 Dec; 5(23):. PubMed ID: 29199179 [TBL] [Abstract][Full Text] [Related]
30. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Strader AD; Vahl TP; Jandacek RJ; Woods SC; D'Alessio DA; Seeley RJ Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E447-53. PubMed ID: 15454396 [TBL] [Abstract][Full Text] [Related]
31. Glucagon-like peptide-1 7-36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man. Wettergren A; Petersen H; Orskov C; Christiansen J; Sheikh SP; Holst JJ Scand J Gastroenterol; 1994 Jun; 29(6):501-5. PubMed ID: 7915853 [TBL] [Abstract][Full Text] [Related]
32. Glucagon-like peptide-1-(7-36) amide and peptide YY mediate intraduodenal fat-induced inhibition of acid secretion in dogs. Fung LC; Chisholm C; Greenberg GR Endocrinology; 1998 Jan; 139(1):189-94. PubMed ID: 9421414 [TBL] [Abstract][Full Text] [Related]
33. Secretion of ghrelin from rat stomach ghrelin cells in response to local microinfusion of candidate messenger compounds: a microdialysis study. de la Cour CD; Norlén P; Håkanson R Regul Pept; 2007 Oct; 143(1-3):118-26. PubMed ID: 17573135 [TBL] [Abstract][Full Text] [Related]
34. Comparison of the postprandial release of peptide YY and proglucagon-derived peptides in the rat. Anini Y; Fu-Cheng X; Cuber JC; Kervran A; Chariot J; Roz C Pflugers Arch; 1999 Aug; 438(3):299-306. PubMed ID: 10398859 [TBL] [Abstract][Full Text] [Related]
36. Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum. Hansen L; Hartmann B; Bisgaard T; Mineo H; Jørgensen PN; Holst JJ Am J Physiol Endocrinol Metab; 2000 Jun; 278(6):E1010-8. PubMed ID: 10827002 [TBL] [Abstract][Full Text] [Related]
37. Bombesin potentiates taurocholic acid-induced neurotensin release in rats. Herrmann C; Cuber JC; Dakka T; Bernard C; Chayvialle JA Endocrinology; 1991 Jun; 128(6):2853-7. PubMed ID: 1709858 [TBL] [Abstract][Full Text] [Related]
38. What do we know about the secretion and degradation of incretin hormones? Deacon CF Regul Pept; 2005 Jun; 128(2):117-24. PubMed ID: 15780431 [TBL] [Abstract][Full Text] [Related]
39. Neuropeptide Y and peptide YY, but not pancreatic polypeptide, substance P, cholecystokinin and gastric inhibitory polypeptide, inhibit the glucagon- and noradrenaline-dependent increase in glucose output in rat liver. Lüers C; Gardemann A; Miura H; Jungermann K Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):455-62. PubMed ID: 10784001 [TBL] [Abstract][Full Text] [Related]
40. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; Wang F; Kent AS; Frost GS; Ghatei MA; Bloom SR Endocrinology; 2005 Dec; 146(12):5120-7. PubMed ID: 16150917 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]